| Substance |
Route of Elimination |
Effect when Combined with ARV Therapy Agents
|
| Alcohol |
Metabolized by alcohol dehydrogenase |
↑ ABC AUC 41% – Clinical significance likely minimal |
| Amphetamines |
Metabolized by CYP2D6 |
Toxicity may be potentiated by ritonavir (low- or full-dose) |
| Barbiturates |
Several are metabolized by CYP3A4 and induce CYP3A4 |
May ↓ PIs, NNRTIs, MVC, and RAL. Avoid co-administration or use with close monitoring. |
| Benzodiazepines |
Several are metabolized by CYP3A4 (midazolam, triazolam) |
Oral midazolam and triazolam are contraindicated with PIs, EFV, and DLV. IV midazolam may be co-administered with very close monitoring. Consider alternative benzodiazepines (lorazepam, oxazepam, or temazepam) with ARV therapy co-administration. |
| Cocaine |
Minor metabolism by CYP3A4 to hepatotoxic metabolite |
None known |
Gamma hydroxybutyrate (GHB) |
Metabolized by CYP2D6 Eliminated via first pass metabolism |
RTV and other boosted PIs may precipitate life-threatening toxicity when GHB used concurrently |
| Heroin |
Metabolized to morphine, then to morphine-6-glucuronide via glucuronidation |
None known |
| Ketamine |
Metabolized via CYP2B6, 3A4, and 2C9 |
PIs, DLV, and ETR may significantly ↑ ketamine serum concentrations |
| Marijuana |
Metabolized via hydroxylation, some involvement of CYP3A4, 2C9, and 2C6 |
Effect of smoked marijuana and oral tablets on IDV or NFV concentrations not clinically significant |
| Meperidine |
Metabolized via hydroxylation and CYP450, CYP2D6, and CYP1A2 |
Ritonavir associated with ↓ meperidine AUC by 67% and ↑ normeperidine AUC by 47%. Avoid co-administration with any boosted PI. |
| Methylenedioxy-methamphetamine (MDMA) |
Metabolized via CYP2D6 |
RTV and other boosted PIs may precipitate life-threatening toxicity when MDMA used concurrently |
| Morphine |
Metabolism via glucuronidation |
None known |
| Oxycodone |
Metabolized via CYP2D6 to oxymorphone CYP3A4 to noroxycodone ketoreductase |
None known |
| PCP |
Metabolized via CYP3A, 2C11; inhibits CYP2B1 |
PIs and DLV may significantly ↑ PCP serum concentrations |
Facebook Twitter LinkedIn